Search results for "Dystrophy"

showing 10 items of 268 documents

Bortezomib Partially Improves Laminin α2 Chain–Deficient Muscular Dystrophy

2014

Congenital muscular dystrophy, caused by mutations in LAMA2 (the gene encoding laminin α2 chain), is a severe and incapacitating disease for which no therapy is yet available. We have recently demonstrated that proteasome activity is increased in laminin α2 chain-deficient muscle and that treatment with the nonpharmaceutical proteasome inhibitor MG-132 reduces muscle pathology in laminin α2 chain-deficient dy(3K)/dy(3K) mice. Here, we explore the use of the selective and therapeutic proteasome inhibitor bortezomib (currently used for treatment of relapsed multiple myeloma and mantle cell lymphoma) in dy(3K)/dy(3K) mice and in congenital muscular dystrophy type 1A muscle cells. Outcome measu…

Proteasome Endopeptidase ComplexApoptosisBiologyPathology and Forensic MedicineBortezomibmedicineAnimalsMyocyteMuscular dystrophyCells CulturedMultiple myelomaMuscle CellsMyogenesisBortezomibMusclesBody WeightMuscular Dystrophy Animalmedicine.diseaseBoronic AcidsFibrosisSurvival AnalysisMice Inbred C57BLDisease Models AnimalMicroRNAsGene Expression RegulationOrgan SpecificityPyrazinesCongenital muscular dystrophyCancer researchProteasome inhibitorMantle cell lymphomaLamininLocomotionmedicine.drugThe American Journal of Pathology
researchProduct

The four murine peroxisomal ABC-transporter genes differ in constitutive, inducible and developmental expression.

1999

Four ATP-binding cassette (ABC) half-transporters have been identified in mammalian peroxisomes: adrenoleukodystrophy protein (ALDP), adrenoleukodystrophy-related protein (ALDRP), 70-kDa peroxisomal membrane protein (PMP70) and PMP70-related protein (P70R). Inherited defects in ALDP cause the neurodegenerative disorder X-linked adrenoleukodystrophy (X-ALD). By comparative Northern blot analyses we found each of the four murine peroxisomal ABC transporter mRNA species at maximum abundance only in a few tissues, which differed for each family member. The four genes were also regulated differentially during mouse brain development: ALDP mRNA was most abundant in embryonic brain and gradually d…

Response elementMolecular Sequence DataATP-binding cassette transporterMice Inbred StrainsBiologyATP Binding Cassette Transporter Subfamily DBiochemistryATP Binding Cassette Transporter Subfamily D Member 1MiceFenofibrateGene expressionmedicinePeroxisomesAnimalsNorthern blotATP Binding Cassette Transporter Subfamily B Member 1RNA MessengerPromoter Regions GeneticGeneHypolipidemic AgentsMice KnockoutMessenger RNABrainGene Expression Regulation DevelopmentalMembrane ProteinsProteinsBiological Transportmedicine.diseaseMolecular biologyNuclear receptorLiverAdrenoleukodystrophyATP-Binding Cassette TransportersEuropean journal of biochemistry
researchProduct

Ultrastructural study of the retina in late infantile metachromatic leukodystrophy.

1992

The autopsy of a 2-year-old girl revealed a clinically unrecognized metachromatic leukodystrophy (MLD) due to an aryl-sulfatase A deficiency, characteristically affecting the central and peripheral nervous system by demyelination and by accumulation of metachromatic material. The retina though reported clinically as normal, showed the same demyelinating process in the optic nerve including the papilla but an additional intraneuronal storage of MLD-typical lysosomal residual bodies in ganglion cell perikarya of the retina. Cells of the bipolar and photoreceptor layers as well as pigment epithelial cells were not affected by MLD-specific lysosomal storage. Thus, sulfatides seem to play a part…

Retinal Ganglion CellsPathologymedicine.medical_specialtyAutopsyBiologycomplex mixturesRetinaCellular and Molecular NeuroscienceRetinal DiseasesmedicineHumansRetinaBrainGeneral MedicineLeukodystrophy Metachromaticmedicine.diseaseeye diseasesSensory SystemsGanglionMajor duodenal papillaMetachromatic leukodystrophyOphthalmologymedicine.anatomical_structurePeripheral nervous systemChild PreschoolOptic nerveUltrastructureFemalesense organsLysosomesOphthalmic research
researchProduct

Algodystrophy of the hand: innovation therapeutical, pharmacological and rehabilitative strategies

2012

An early rehabilitation program, in combination with proper medication, can prevent the worsen of the hand algo-dystrophy towards a permanent framework characterized by muscle-tendon stiffness, contractures and ankylosis of the distal small joints. We can assert, consequently, that synergy between functional rehabilitation, treatment with disodium clodronate, PEMF and Laser Nd-Yag is a main point for therapeutic efficacy

Settore MED/34 - Medicina Fisica E RiabilitativaAlgodystrophy hand laser nd-yag
researchProduct

The metabolic syndrome and HIV infection.

2013

The metabolic syndrome (MetS), a cluster of risk factors for cardiovascular disease and type 2 diabetes, has become an important public health problem. Considerable differences in the prevalence of the MetS in human immunodeficiency virus (HIV)-infected subjects have been reported, as a consequence of several limitations regarding the diagnostic critera for MetS. New evidence suggests that the use of optimal waist cut-off points specific for the various ethnic populations could represent a step forward in overcoming these limitations. Also the use of specific cut-off points for measuring upper trunk fat as an adjunctive criterion of MetS in HIV patients with lipodystrophy could represent an…

The Metabolic Syndrome HIV Infection.medicine.medical_specialtyAnti-HIV AgentsPopulationAdipokineHIV InfectionsType 2 diabetesDiseaseRisk FactorsInternal medicineDrug DiscoveryEpidemiologymedicineHumanseducationPharmacologyMetabolic Syndromeeducation.field_of_studybusiness.industryPublic healthmedicine.diseaseImmunologyLipodystrophyMetabolic syndromeInsulin ResistancebusinessCurrent pharmaceutical design
researchProduct

Design of novel small molecule base-pair recognizers of toxic CUG RNA transcripts characteristics of DM1.

2020

Graphical abstract

Untranslated regioncongenital hereditary and neonatal diseases and abnormalitiesBase pairMyotonic dystrophyBiophysicsComputational biologyBase recognitionBiologyBiochemistry03 medical and health scienceschemistry.chemical_compound0302 clinical medicineStructural BiologyRNA targetingGeneticsMBNL1030304 developmental biologyComputingMethodologies_COMPUTERGRAPHICS0303 health sciencesDrug discoveryAlternative splicingRNABiological activityNon-coding RNAComputer Science Applicationschemistry030220 oncology & carcinogenesisMolecular modellingTP248.13-248.65Small moleculeBiotechnologyResearch ArticleComputational and structural biotechnology journal
researchProduct

Myotonic dystrophy associated expanded CUG repeat muscleblind positive ribonuclear foci are not toxic to Drosophila

2005

Myotonic dystrophy type 1 is an autosomal dominant disorder associated with the expansion of a CTG repeat in the 3 0 untranslated region (UTR) of the DMPK gene. Recent data suggest that pathogenesis is predominantly mediated by a gain of function of the mutant transcript. In patients, these expanded CUG repeat-containing transcripts are sequestered into ribonuclear foci that also contain the muscleblind-like proteins. To provide further insights into muscleblind function and the pathogenesis of myotonic dystrophy, we generated Drosophila incorporating CTG repeats in the 3 0 -UTR of a reporter gene. As in patients, expanded CUG repeats form discrete ribonuclear foci in Drosophila muscle cell…

Untranslated regioncongenital hereditary and neonatal diseases and abnormalitiesRNA StabilityProtein Serine-Threonine KinasesBiologyMyotonic dystrophyMyotonin-Protein KinaseGeneticsmedicineAnimalsHumansMyotonic Dystrophy3' Untranslated RegionsMolecular BiologyGeneGenetics (clinical)GeneticsRNAGeneral MedicineNuclear matrixbiology.organism_classificationmedicine.diseaseCell biologyRNA silencingDrosophila melanogasterRNA splicingDrosophila melanogasterTrinucleotide Repeat ExpansionHuman Molecular Genetics
researchProduct

July 2003: 62-year-old female with progressive muscular weakness

2004

The July 2003 Case of the Month (COM). A 62-year-old female patient experienced progressive muscular weakness over the last ten years, involving shoulder and pelvic girdle muscles, paraspinal and facial muscles. A biopsy was taken from the left deltoid muscle where hepatitis vaccination had taken place 4 weeks previously. The specimen revealed macrophagic myofasciitis due to the injection of aluminium-bound vaccines. The finding can be reproduced experimentally by injecting vaccines in rats. The pathomechanism is supposed to involve immune stimulation due to long term persistence of the adjuvant. Macrophagic myofasciitis has been suggested to occasionally cause myopathy but is supposed to b…

Viral Hepatitis Vaccinesmedicine.medical_specialtyAluminum HydroxideMass SpectrometryCases of the Month: July to September 2003Pathology and Forensic MedicineDiagnosis DifferentialBiopsymedicineHumansMuscle SkeletalMyopathyInclusion BodiesHepatitisMuscle WeaknessPelvic girdlemedicine.diagnostic_testbusiness.industryMacrophagesGeneral NeuroscienceMacrophagic myofasciitisMiddle Agedmedicine.diseaseMuscular Dystrophy FacioscapulohumeralSurgeryVaccinationMicroscopy ElectronFacial musclesmedicine.anatomical_structureFemaleNeurology (clinical)medicine.symptombusinessProgressive muscular weaknessBrain Pathology
researchProduct

Pattern Dystrophy of the Macula in a Case of Steinert Disease

2013

<b><i>Introduction:</i></b> Myotonic dystrophies are typically associated with ocular complications like ptosis, weakness of the ocular muscle and cataracts, but also with less recognized retinal changes. <b><i>Case Report:</i></b> A 41-year-old female with type 1 myotonic dystrophy complained of progressive vision loss. Slit lamp examination revealed the presence of typical bilateral polychromatic cataract with posterior subcapsular component. Dilated fundus examination was remarkable for bilateral macular depigmented changes. Multimodal imaging analysis of the macula suggested the presence of a butterfly-shaped pattern dystrophy. <b>&l…

Weaknessmedicine.medical_specialtygenetic structuresPattern dystrophyMyotonic dystrophyMyotonic dystrophychemistry.chemical_compoundPtosisCataractslcsh:OphthalmologySteinert diseaseOphthalmologyMaculopathyMedicinePublished online: September 2013business.industryRetinalmedicine.diseaseDilated fundus examinationPattern dystrophyeye diseasesSurgeryOphthalmologyAcquired vitelliform depositchemistrylcsh:RE1-994Maculopathysense organsmedicine.symptombusinessCase Reports in Ophthalmology
researchProduct

Alternative splicing regulation by Muscleblind proteins: from development to disease.

2011

Regulated use of exons in pre-mRNAs, a process known as alternative splicing, strongly contributes to proteome diversity. Alternative splicing is finely regulated by factors that bind specific sequences within the precursor mRNAs. Members of the Muscleblind (Mbl) family of splicing factors control critical exon use changes during the development of specific tissues, particularly heart and skeletal muscle. Muscleblind homologs are only found in metazoans from Nematoda to mammals. Splicing targets and recognition mechanisms are also conserved through evolution. In this recognition, Muscleblind CCCH-type zinc finger domains bind to intronic motifs in pre-mRNA targets in which the protein can e…

Zinc fingerGeneticsAlternative splicingExonic splicing enhancerRNA-Binding ProteinsRNA-binding proteinBiologyGeneral Biochemistry Genetics and Molecular BiologyCell biologyExonchemistry.chemical_compoundAlternative SplicingchemistryGene Expression RegulationMultigene FamilyProteomeRNA splicingMBNL1AnimalsHumansMyotonic DystrophyRNAGeneral Agricultural and Biological SciencesProtein BindingBiological reviews of the Cambridge Philosophical Society
researchProduct